The effects of losartan compared to atenolol on stroke in patients with isolated systolic hypertension and left ventricular hypertrophy. The LIFE study
- Kjeldsen, SE
- Lyle, PA
- Kizer, JR
- Dahlof, B
- Devereux, RB
- Julius, S
- Beevers, David
- de Faire, U
- Fyhrquist, F
- Ibsen, H
- Kristianson, K
- Lederballe-Pedersen, O
- Lindholm, JH
- Nieminen, MS
- Omvik, P
- Oparil, S
- Snappin, S
- Harris, KE
- Wedel, H
Publication date
March 2005
DOIAbstract
The Losartan Intervention For Endpoint reduction in hypertension (LIFE) study reported that a losartan-based antihypertensive regimen reduced cardiovascular morbidity and mortality (composite of cardiovascular death, stroke, and myocardial infarction) more than therapy based on atenolol in patients with left ventricular hypertrophy and isolated systolic hypertension (ISH). Patients aged 55-80 years with blood pressures 160-200
Add to ORKG